Study the effect of Anacardium occidentale-derived product on oxidative stress, inflammations, advanced glycation end product, homocysteine and immune in middle-aged and elderly volunteers

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

TCTR

Registry ID

TCTR20200410006

Enrollment

Registered

2020-04-10

Start date

2020-06-05

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy conditions Cashew Anacardium occidentale functional food oxidative stress inflammations immune advanced glycation end product homocysteine middle-aged elderly

Interventions

Subjects are received the instant beverage containing the extract of Cashew 60 g/day,Subjects are received the instant beverage containing the extract of Cashew 30 g/day,Subjects are received the plac

Experimental Dietary Supplement,Experimental Dietary Supplement,Placebo Comparator Dietary Supplement

Instant beverage from Cashew 60 g/day, Instant beverage from Cashew 30 g/day,Placebo

Eligibility

Sex/Gender

All

Age

40 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Healthy volunteers aged between 40-65 years old 2.All volunteers don't have serious physical illness and mental disorder

Exclusion criteria

Exclusion criteria: 1.Volunteers who require supplements or herbs or drugs at least 2 months before participating in this study and during the trial 2.Women who being pregnant 3.Smoking more than 10 pieces/day 4.Drinking alcohol more than 5 units/day 5.Volunteers who use probiotics

Design outcomes

Primary

Measure	Time frame
Oxidative stress markers 8 weeks Elisa method	—

Secondary

Measure	Time frame
The changes of hematological and clinical chemistry parameters 8 weeks laboratory,Phenolic compounds and Flavonoids 8 weeks Elisa method,Inflammatory markers 8 weeks Elisa method,Immune markers 8 weeks Elisa method,Homocysteine 8 weeks laboratory,Advance glycation end product (AGE) 8 weeks Elisa method,Electrocardiogram 8 weeks electrocardiograph,Dietary Questionnaire 8 weeks Questionaire,Safety evaluation and side effect 8 weeks Questionaire	—

Measure

Time frame

The changes of hematological and clinical chemistry parameters 8 weeks laboratory,Phenolic compounds and Flavonoids 8 weeks Elisa method,Inflammatory markers 8 weeks Elisa method,Immune markers 8 weeks Elisa method,Homocysteine 8 weeks laboratory,Advance glycation end product (AGE) 8 weeks Elisa method,Electrocardiogram 8 weeks electrocardiograph,Dietary Questionnaire 8 weeks Questionaire,Safety evaluation and side effect 8 weeks Questionaire

—

Countries

Thailand

Contacts

Public ContactJintanaporn Wattanathorn

Khon Kaen University

jinwat@kku.ac.th0818721809

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026